Brief: Suven Life Sciences secures one product patent in India
Dec 7 (Reuters) - Suven Life Sciences Ltd SUVP.NS
* Says Suven Life Sciences secures one (1) product patent in
India
* Says patent is valid through 2024
* Patent corresponds to new chemical entities (NCEs) for
treatment of disorders associated with neurodegenerative
diseases
Source text: http://bit.ly/2giWvUD
Further company coverage: SUVP.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees